Breaking News Instant updates and real-time market news.

KO

Coca-Cola

$46.01

0.19 (0.41%)

, PEP

PepsiCo

$112.91

-0.11 (-0.10%)

10:17
08/14/18
08/14
10:17
08/14/18
10:17

BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore

Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note.

KO

Coca-Cola

$46.01

0.19 (0.41%)

PEP

PepsiCo

$112.91

-0.11 (-0.10%)

KDP

Keurig Dr Pepper

$23.51

-0.24 (-1.01%)

KO Coca-Cola
$46.01

0.19 (0.41%)

07/26/18
RHCO
07/26/18
NO CHANGE
Target $55
RHCO
Buy
Coca-Cola price target raised to $55 from $50 at SunTrust
SunTrust analyst William Chappell raised his price target on Coca-Cola to $55 and kept his Buy rating, saying the company addressed his concerns about the negative price-mix in North America as pricing actually rose in low-single-digits in Q2. The analyst notes that his new price target implies a forward price earnings multiple of 24-times - a premium relative to peers based on the company's "strong organic growth performance".
05/17/18
05/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coca-Cola (KO) upgraded to Overweight from Equal Weight at Barclays with analyst Lauren Lieberman saying the company's transformation should drive "sustainably better growth," which should yield a higher valuation premium. 2. Valero (VLO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Benny Wong saying recent underinvestment in refining, slippages in capacity additions and overdone concerns on long-term demand have set the stage for refining to enter a "golden age" through 2020. 3. ManTech (MANT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Edward Caso citing valuation. 4. Celanese (CE) upgraded to Buy from Neutral at UBS with analyst John Roberts saying he believes the shares are undervalued and investors do not appreciate the stability and growth in the acetyls chain and the long-term potential in Engineered Materials. 5. Canadian National (CNI) upgraded to Buy from Underperform at BofA/Merrill with analyst Ken Hoexter saying service and volume growth rebounded faster than expected and will only be aided by an improving economy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
PEP PepsiCo
$112.91

-0.11 (-0.10%)

07/24/18
RHCO
07/24/18
NO CHANGE
Target $110
RHCO
Hold
PepsiCo price target raised to $110 from $105 at SunTrust
SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range.
07/11/18
BMOC
07/11/18
NO CHANGE
Target $110
BMOC
Market Perform
PepsiCo stock price advance looks 'overdone', says BMO Capital
BMO Capital analyst Amit Sharma kept his Market Perform rating and $110 price target on PepsiCo after its Q2 earnings beat, saying the 18% increase in the company's share price over the past two months now looks "overdone". Sharma notes that it is harder to determine whether PepsiCo's earnings growth model is sustainable or stretched "given flexibility around marketing/brands investments", adding that he is also less confident on management's ability/willingness to consistently top consensus. Moreover, despite the company's maintained outlook for FY18, the analyst sees non-recurring items such as the bottling asset sale, tax cuts, and pension income to contribute over 600bps to the expected FY18 EPS growth - a much higher contribution than the 250bps seen in FY17.
07/23/18
JEFF
07/23/18
NO CHANGE
Target $107
JEFF
Hold
Jefferies sees risk of near-term downside in PepsiCo shares
Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target.
KDP Keurig Dr Pepper
$23.51

-0.24 (-1.01%)

07/18/18
GSCO
07/18/18
INITIATION
Target $26
GSCO
Neutral
Keurig Dr Pepper reinstated with a Neutral at Goldman Sachs
Goldman analyst Judy Hong reinstated Keurig Dr Pepper with a Neutral and $26 price target citing valuation.
07/24/18
SUSQ
07/24/18
UPGRADE
SUSQ
Positive
Keurig Dr Pepper upgraded to Positive from Neutral at Susquehanna
07/25/18
07/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Mixed from Negative at Vertical Group with analyst Phil Leggiere citing expectations for strong 2H 2018 spending. 2. Keurig Dr Pepper (KDP) upgraded to Positive from Neutral at Susquehanna. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Cowen with analyst Cai von Rumohr citing its enhanced visibility to roughly 10% growth through 2021, above average cash flow, dividend yield, and attractive risk/reward. 4. Hawaiian Holdings (HA) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Linenberg saying he views last night's quarter as strong and sees an improving CASM trend. 5. Target (TGT) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying geolocation data and proprietary card data support his Q2 4.5% comp. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ACIU

AC Immune

$11.58

0.63 (5.75%)

, LLY

Eli Lilly

$114.49

0.38 (0.33%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
AC Immune, Eli Lilly announce license and collaboration agreement »

AC Immune (ACIU) and Eli…

ACIU

AC Immune

$11.58

0.63 (5.75%)

LLY

Eli Lilly

$114.49

0.38 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OMI

Owens & Minor

$7.11

-0.19 (-2.60%)

06:32
12/12/18
12/12
06:32
12/12/18
06:32
Hot Stocks
Owens & Minor names Robert Snead as EVP & CFO »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

06:31
12/12/18
12/12
06:31
12/12/18
06:31
Downgrade
Black Hills rating change  »

Black Hills downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$62.30

-0.28 (-0.45%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Emerson rating change  »

Emerson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.18

0.53 (0.76%)

06:30
12/12/18
12/12
06:30
12/12/18
06:30
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:29
12/12/18
12/12
06:29
12/12/18
06:29
Periodicals
Google CEO faces questions from lawmakers on alleged political bias, WSJ says »

Google CEO Sundar Pichai…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:27
12/12/18
12/12
06:27
12/12/18
06:27
Hot Stocks
Credit Suisse sees FY18 reported pre-tax income CHF3.2B-CHF3.4B »

Sees FY18 APAC Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$10.92

-0.09 (-0.82%)

06:25
12/12/18
12/12
06:25
12/12/18
06:25
Hot Stocks
Credit Suisse board approves buyback of up to CHF1.5B »

At its 2018 investor day,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

06:22
12/12/18
12/12
06:22
12/12/18
06:22
Periodicals
Chinese hackers behind Marriott data breach, NY Times reports »

The cyberattack on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.40

-1.46 (-2.44%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Initiation
Six Flags initiated  »

Six Flags initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

06:20
12/12/18
12/12
06:20
12/12/18
06:20
Periodicals
Snowden, others call for Pichai to kill Google's 'Project Dragonfly,' BI reports »

NSA whistleblower Edward…

GOOG

Alphabet

$1,051.82

11.8 (1.13%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BY

Byline Bancorp

$18.91

-0.32 (-1.66%)

06:18
12/12/18
12/12
06:18
12/12/18
06:18
Conference/Events
Byline Bancorp management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RY

Royal Bank of Canada

$69.76

-0.44 (-0.63%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Royal Bank of Canada rating change  »

Royal Bank of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

CORT

Corcept Therapeutics

$17.16

4.18 (32.20%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Corcept Therapeutics rating change  »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$116.67

1.66 (1.44%)

06:17
12/12/18
12/12
06:17
12/12/18
06:17
Upgrade
Lululemon rating change  »

Lululemon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BBY

Best Buy

, AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Recommendations
Best Buy, Amazon.com analyst commentary  »

Best Buy…

BBY

Best Buy

AMZN

Amazon.com

$1,643.50

3.13 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

KRYS

Krystal Biotech

$23.49

0.38 (1.64%)

06:16
12/12/18
12/12
06:16
12/12/18
06:16
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.81

-0.19 (-4.75%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Initiation
Foamix initiated  »

Foamix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Periodicals
Nissan shares detailed allegations against Ghosn with Renault, FT reports »

Nissan (NSANY) has shared…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

BHC

Bausch Health

$23.09

0.25 (1.09%)

, SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

06:13
12/12/18
12/12
06:13
12/12/18
06:13
Hot Stocks
Bausch Health to acquire Synergy Pharmaceuticals for $200M through Chapter 11 »

Synergy Pharmaceuticals…

BHC

Bausch Health

$23.09

0.25 (1.09%)

SGYP

Synergy Pharmaceuticals

$0.34

-0.0094 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

EADSY

Airbus

$0.00

(0.00%)

06:11
12/12/18
12/12
06:11
12/12/18
06:11
Periodicals
Airbus staff error led to fatal 2017 German helicopter crash, Reuters reports »

The fatal crash in 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$15.93

-0.075 (-0.47%)

06:09
12/12/18
12/12
06:09
12/12/18
06:09
Downgrade
KeyCorp rating change  »

KeyCorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

06:07
12/12/18
12/12
06:07
12/12/18
06:07
Periodicals
Senate confirms Muzinich as Deputy Treasury Secretary, WSJ reports »

The Senate has confirmed…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAY

Dave & Buster's

$51.08

-1.44 (-2.74%)

06:07
12/12/18
12/12
06:07
12/12/18
06:07
Recommendations
Dave & Buster's analyst commentary  »

Dave & Buster's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

LLY

Eli Lilly

$114.49

0.38 (0.33%)

, ACIU

AC Immune

$11.58

0.63 (5.75%)

06:06
12/12/18
12/12
06:06
12/12/18
06:06
Hot Stocks
Eli Lilly, AC Immune to develop tau aggregation inhibitor small molecules »

Eli Lilly (LLY) and AC…

LLY

Eli Lilly

$114.49

0.38 (0.33%)

ACIU

AC Immune

$11.58

0.63 (5.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.